Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

Reducing SFRP1 can promote hair growth and may help treat hair loss.

Identified genes linked to male-pattern baldness may help develop new treatments.

Future treatments for androgenic alopecia may focus on reactivating hair follicle stem cells and improving drug delivery.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

A specific pathway involving AR, miR-221, and IGF-1 plays a key role in causing common hair loss.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

Higher DHT levels are linked to worse heart changes in severe aortic valve stenosis patients.

Combining minoxidil with ginsenoside Rg3 and glycyrrhizic acid offers a more effective treatment for androgenic alopecia.

Hair growth is influenced by dynamic changes in hair follicle cells, which could help treat hair loss.

m6A deregulation plays a key role in PCOS and could lead to new treatments.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

Stereotactic body radiation therapy and radiosurgery are advanced, precise treatments that target tumors while protecting healthy tissue.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Steroid sulfatase in hair follicles may be a target for treating hair loss.

Prolactin may influence skin glands and could be a target for treating acne and skin aging.

Testosterone pellet therapy may better address hormone imbalances in aging by focusing on local hormone production and symptom relief.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Certain miRNAs may play a role in sheep hair follicle development, which could help improve wool production.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.